Fernwood Investment Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-3,300
Closed -$259K 128
2015
Q4
$259K Sell
3,300
-4,000
-55% -$314K 0.22% 94
2015
Q3
$550K Buy
7,300
+500
+7% +$47.3K 0.48% 57
2015
Q2
$794K Hold
6,800
0.62% 48
2015
Q1
$1.61M Buy
6,800
+100
+1% +$21.4K 1.32% 28
2014
Q4
$1.27M Hold
6,700
1.08% 35
2014
Q3
$1.6M Buy
6,700
+3,500
+109% +$719K 1.37% 29
2014
Q2
$211K Hold
3,200
0.17% 104
2014
Q1
$333K Hold
3,200
0.31% 79
2013
Q4
$331K Buy
+3,200
New +$188K 0.22% 104

Other funds holding PBYI

Fernwood Investment Management's PBYI Position: Q1 2016 in Review

Fernwood Investment Management sold out of Puma Biotechnology (PBYI) in Q1 2016, closing a stake of 3,300 shares — an estimated $259K sold.

Fernwood Investment Management first reported a position in PBYI in Q4 2013 and held it in 9 quarters. The position peaked at $1.61M in Q1 2015. 119 funds tracked by Wall St. Rank hold PBYI as of Q1 2016.

  • Fernwood Investment Management reported no remaining Puma Biotechnology position as of Q1 2016 after selling out during the quarter.
  • Fernwood Investment Management sold 3,300 Puma Biotechnology shares in Q1 2016, an estimated $259K.
  • Fernwood Investment Management first reported a position in Puma Biotechnology in Q4 2013 and held it in 9 quarters.
  • Fernwood Investment Management's Puma Biotechnology position peaked at $1.61M in Q1 2015.
  • 119 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2016.

Based on Fernwood Investment Management's 13F filing for Q1 2016, filed 10 May 2016.